Niesters HG - Search Results

1

Persistence of YMDD variants after withdrawal of Lamivudine.

van der Eijk AA, Niesters HG, Pas SD, de Man RA. van der Eijk AA, et al. Among authors: niesters hg. J Hepatol. 2002 Feb;36(2):304-5. doi: 10.1016/s0168-8278(01)00250-1. J Hepatol. 2002. PMID: 11830347 No abstract available.

2

The influence of baseline characteristics on viral dynamic parameters in chronic hepatitis B patients treated with lamivudine.

Wolters LM, Hansen BE, Niesters HG, Levi-Drummer RS, Neumann AU, Schalm SW, de Man RA. Wolters LM, et al. Among authors: niesters hg. J Hepatol. 2002 Aug;37(2):253-8. doi: 10.1016/s0168-8278(02)00113-7. J Hepatol. 2002. PMID: 12127431 Clinical Trial.

3

Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns.

Honkoop P, Niesters HG, de Man RA, Osterhaus AD, Schalm SW. Honkoop P, et al. Among authors: niesters hg. J Hepatol. 1997 Jun;26(6):1393-5. doi: 10.1016/s0168-8278(97)80476-x. J Hepatol. 1997. PMID: 9210628

4

Selection of an entecavir-resistant mutant despite prolonged hepatitis B virus DNA suppression, in a chronic hepatitis B patient with preexistent lamivudine resistance: successful rescue therapy with tenofovir.

Leemans WF, Niesters HG, van der Eijk AA, Janssen HL, Schalm SW, de Man RA. Leemans WF, et al. Among authors: niesters hg. Eur J Gastroenterol Hepatol. 2008 Aug;20(8):773-7. doi: 10.1097/MEG.0b013e3282f793d6. Eur J Gastroenterol Hepatol. 2008. PMID: 18617782

5

Viral dynamics in chronic hepatitis B patients during lamivudine therapy.

Wolters LM, Hansen BE, Niesters HG, Zeuzem S, Schalm SW, de Man RA. Wolters LM, et al. Among authors: niesters hg. Liver. 2002 Apr;22(2):121-6. doi: 10.1034/j.1600-0676.2002.01579.x. Liver. 2002. PMID: 12028405 Clinical Trial.

6

Viral dynamics during and after entecavir therapy in patients with chronic hepatitis B.

Wolters LM, Hansen BE, Niesters HG, DeHertogh D, de Man RA. Wolters LM, et al. Among authors: niesters hg. J Hepatol. 2002 Jul;37(1):137-44. doi: 10.1016/s0168-8278(02)00115-0. J Hepatol. 2002. PMID: 12076873

7

The dynamics of mutations in the YMDD motif of the hepatitis B virus polymerase gene during and after lamivudine treatment as determined by reverse hybridisation.

Pas SD, de Man RA, Fries E, Osterhaus AD, Niesters HG. Pas SD, et al. Among authors: niesters hg. J Clin Virol. 2002 Jul;25(1):63-71. doi: 10.1016/s1386-6532(01)00251-7. J Clin Virol. 2002. PMID: 12126723

8

Identification of a new variant in the YMDD motif of the hepatitis B virus polymerase gene selected during lamivudine therapy.

Niesters HGM, DE Man RA, Pas SD, Fries E, Osterhaus ADME. Niesters HGM, et al. J Med Microbiol. 2002 Aug;51(8):695-699. doi: 10.1099/0022-1317-51-8-695. J Med Microbiol. 2002. PMID: 12171302 Free article.

9

Viral dynamics in chronic hepatitis B patients treated with lamivudine, lamivudine-famciclovir or lamivudine-ganciclovir.

Wolters LM, Hansen BE, Niesters HG, de Man RA. Wolters LM, et al. Among authors: niesters hg. Eur J Gastroenterol Hepatol. 2002 Sep;14(9):1007-11. doi: 10.1097/00042737-200209000-00012. Eur J Gastroenterol Hepatol. 2002. PMID: 12352221 Clinical Trial.

10

Polyarteritis nodosa associated with hepatitis B virus infection. The role of antiviral treatment and mutations in the hepatitis B virus genome.

Janssen HL, van Zonneveld M, van Nunen AB, Niesters HG, Schalm SW, de Man RA. Janssen HL, et al. Among authors: niesters hg. Eur J Gastroenterol Hepatol. 2004 Aug;16(8):801-7. doi: 10.1097/01.meg.0000108362.41221.57. Eur J Gastroenterol Hepatol. 2004. PMID: 15256984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters